Precision Medicine

The new functionalities allow customers to integrate existing processing pipelines so they can quickly build applications and scale up robust genomic analyses and secondary analyses. 

J29 supports the "HIMSS Gives Back" initiative and has public and private partnerships central to its mission. J29 president and founder Tracy Mills and VP of HHS Programs Nick Vass offer a deep dive.

HIMSS23 keynote speaker Salim Ismail, founder and chair of OpenExO, talks about the decade of Exponential Organizations.

The FHIR-enabled platform supports provider tools that integrate algorithms and machine learning to improve patient diagnoses.

At HIMSS23, panelists discussed how genomics could improve patient care and the challenges to implementing genetic testing programs.

Sonya Makhni, medical director of the Mayo Clinic Platform, discusses a model that brings the disparate pieces of a fractured healthcare ecosystem together in her keynote at the HIMSS23 ML and AI Forum. 

With quantum computing now a reality, and poised to turbocharge machine learning and precision medicine across healthcare, one expert who's speaking at HIMSS23 says it's time to prepare.

In a preview of his HIMSS23 presentation, Dr. Cecil Lynch, chief medical information officer at Accenture, describes the current role of genomics in healthcare and discusses how to ensure innovations are more widely used to ensure value-based care.

The new Quantum System One platform, part of a 10 year advanced computing collaboration first announced in 2021, will help accelerate precision medicine research and drug development for an array of medical conditions.

The agency says the current policies, guidelines and controls for the cybersecurity and privacy of genomic data are inadequate and asks the public to comment on proposed use cases and protections.